Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2026-04-07 @ 3:26 PM
Study NCT ID:
NCT03957551
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-21
First Post:
2019-05-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma
Sponsor:
Organization: